These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17536304)

  • 21. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
    Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
    Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
    Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
    Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of hypoxia inducible factor-1alpha and relationship thereof to apoptosis related protein in non-small cell lung cancer].
    Chen YF; Yang HP; Hu JL; Zhou XD; Xiong W; Dai XT; Li XJ
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):921-3. PubMed ID: 17650407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and clinical significance of caspase-3,survivin and k-ras in non-small cell lung cancer.].
    Li C; Hu B; Wang X; Ji C; He Y
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):90-6. PubMed ID: 20727274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
    Duan L; Hu X; Jin Y; Liu R; You Q
    BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
    Hinnis AR; Luckett JC; Walker RA
    Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
    Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
    Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
    Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear survivin as a biomarker for non-small-cell lung cancer.
    Lu B; Gonzalez A; Massion PP; Shyr Y; Shaktour B; Carbone DP; Hallahan DE
    Br J Cancer; 2004 Aug; 91(3):537-40. PubMed ID: 15266313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
    Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
    Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
    Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of survivin in human gastric adenocarcinomas: correlation with proliferation and apoptosis].
    Yao XQ; Liu FK; Qi XP; Wu B; Yin HL; Ma HH; Shi QL; Zhou XJ; Li JS
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):145-8. PubMed ID: 15062058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
    Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Chiyo M; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Agamy G; El-Shahhat H; Fujisawa T; Yoshino I
    Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
    Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
    Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
    Porebska I; Sobańska E; Kosacka M; Jankowska R
    Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis.
    Yoo J; Jung JH; Lee MA; Seo KJ; Shim BY; Kim SH; Cho DG; Ahn MI; Kim CH; Cho KD; Kang SJ; Kim HK
    J Korean Med Sci; 2007 Apr; 22(2):318-25. PubMed ID: 17449943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.
    Nakashima N; Liu D; Huang CL; Ueno M; Zhang X; Yokomise H
    Lung Cancer; 2012 May; 76(2):228-34. PubMed ID: 22070884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.